Evidence map›Paper›PMID 39553538›Full record

ArticleJournal of health economics and outcomes research2024

We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?

Rebecca Smith, Samara Eisenberg, Aaron Turner-Pfifer, Jacqueline LeGrand, Sarah Pincus, Yousra Omer, Fei Wang, Bruce Pyenson

Abstract read
In one paragraph

Article in Journal of health economics and outcomes research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The Urgent Need for Breakthrough Therapies and a World Without Type 1 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca SmithMilliman, Inc., New York, NY, USA.
Samara EisenbergMilliman, Inc., New York, NY, USA.
Aaron Turner-PfiferBreakthrough T1D, Washington, DC, USA.
Jacqueline LeGrandBreakthrough T1D.
Sarah PincusBreakthrough T1D, Washington, DC, USA.
Yousra OmerBreakthrough T1D, Washington, DC, USA.
Fei WangBreakthrough T1D, Washington, DC, USA.
Bruce PyensonHealth Milliman, Inc., New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

administrative claimscontinuous glucose monitordemographic projectiondiabetes forecastinsulin pumppopulation healthreal-world datasocioeconomic determinantstype 1 diabetes

Identifiers

PMID39553538
PMCPMC11566618

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.